Payrolls, mega-cap tech earnings, Nvidia - what's moving markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Morgan Stanley on Boeing (BA): 'It is still too early, in our view, to know if Boeing is out of the woods'
February 6, 2024 4:28 PM ESTMorgan Stanley analyst Kristine Liwag reiterated an Equalweight rating and $235.00 price target on Boeing (NYSE: BA)
The analyst comments "Today, the National Transportation Safety Board released its preliminary report on Alaska Airlines flight 1282 (link). The report represents the most comprehensive detailing of the... More
UBS Reviews Apple (AAPL) App Store for January
February 6, 2024 9:32 AM ESTUBS analyst David Vogt reiterated a Neutral rating and $190.00 price target on Apple (NASDAQ: AAPL).
The analyst comments "Our analysis of Apple's App Store suggests rev in the month of January was up ~5% vs 10% growth Sept-23 through Dec-23 (Source: Sensor... More
Citi's Take on Apple (AAPL) and Hon Hai Jan Revenue Implications
February 5, 2024 8:48 AM ESTCiti analyst Atif Malik reiterated a Buy rating and $225.00 price target on Apple (NASDAQ: AAPL)
The analyst comments "Hon Hai, ~ 50% Apple sales exposure, reported Jan revenue before the market open with +13% M/M (above 3-year seasonal average of -21%)... More
Abbvie (ABBV) PT Raised to $180 at Goldman Sachs
February 5, 2024 5:58 AM ESTGoldman Sachs analyst Chris Shibutani raised the price target on Abbvie (NYSE: ABBV) to $180.00 (from $173.00) while maintaining a Buy rating.
The analyst comments "4Q23 results and management's commentary on the FY24 and longer-term outlook strengthen our confidence in the potential for ABBV shares to continue to outperform. Across the company's Immunology... More
7 Themes to watch in 2024
February 4, 2024 2:00 PM ESTGoldman Sachs recently released its January update, presenting the "Top Themes" that their analysts believe investors should watch in 2024. Alongside this, the equity research firm made notable changes to its Conviction List, adding Parker Hannifan (NYSE: PH) and Textron (NYSE: TXT) while removing Bath & Body Works (NYSE: BBWI), Boeing (NYSE: BA), Shift4 Payments (NYSE: FOUR), and AIG (NYSE: AIG).
The Conviction List is Goldman Sachs' strategic approach to identifying... More
NVIDIA (NVDA) target lifted at BofA as AI dominance expected to continue
February 2, 2024 10:11 AM ESTBank of America analyst Vivek Arya raised the firm's price target for NVIDIA (NASDAQ: NVDA) to $800 from $700 per share in a note Friday, reiterating its Buy rating and top pick designation on the stock, noting its "compelling valuation."
Arya said, ahead of NVDA's earnings report on February 21, that they are looking for a notable but more measured 3% to 5% or $500 million to $1 billion upside... More
AbbVie (ABBV) tops Q4 earnings, revenue consensus estimate
February 2, 2024 8:37 AM ESTAbbVie (NYSE: ABBV) shares edged around 1% higher early Friday after the company reported earnings before the open, topping fourth-quarter profit and revenue expectations.
The American pharmaceutical company reported fourth-quarter adjusted earnings of $2.79 per share, $0.02 better than the analyst estimate of $2.77. Meanwhile, revenue... More
